{"data":{"id":"us/42-cfr-423.2724","jurisdiction":"us","citation":"42 CFR 423.2724","heading":"Effect of manufacturer acquisition on phase-in eligibility.","body":"For purposes of the Manufacturer Discount Program, when a manufacturer acquires another manufacturer after 2021 (that is, the acquired manufacturer becomes part of such acquiring manufacturer under the aggregation rule at § 423.2716(c)), the acquired manufacturer assumes the phase-in status of the acquiring manufacturer, effective at the beginning of the plan year immediately following the acquisition or, for an acquisition before 2025, effective January 1, 2025.","path":["Title 42—Public Health","CHAPTER IV—CENTERS FOR MEDICARE \u0026 MEDICAID SERVICES, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER B—MEDICARE PROGRAM","PART 423—VOLUNTARY MEDICARE PRESCRIPTION DRUG BENEFIT","Subpart AA—Medicare Part D Manufacturer Discount Program"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-42.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:26:11Z","sha256":"d6f09349567d4fdd1acba75a2c7c1dc3eb9258407ce3f046eae9d1dcd4335e11","source_id":"us-cfr","stale":true,"prev":"us/42-cfr-423.2720","next":"us/42-cfr-423.2728"},"notice":"GroundRules: Original legal text. Not legal advice."}